Effectiveness, safety, and tolerability of delayed dexamethasone, rituximab, and cyclophosphamide as first-line treatment in patients with Waldenström macroglobulinemia: data from the Sicilian Myeloma Network.

Details

Language :

English

ISSN :

28133935

Database :

Complementary Index

Journal :

Frontiers in Hematology

Publication Type :

Academic Journal

Accession number :

178275760

Full Text :

https://doi.org/10.3389/frhem.2024.1425677